Lewy body diseases (LBDs) are neurodegenerative disorders characterised by the widespread presence of insoluble α-synuclein-containing aggregates, accompanied by the loss of dopaminergic neurons in the substantia nigra pars compacta [1]. This evidence concerns the gene SNCA and Lewy body dementia.